Not Signed In -
ADHD |
ADD; Adult attention Deficit Hyperactivity; Attention Deficit Hyperactivity; Attention Deficit Hyperactivity (ADHD), Adult; Attention Deficit Hyperactivity Disorder; Attention Deficit Hyperactivity Disorder (ADHD); Attention Deficit Hyperactivity Disorder / Adhd; Attention Deficit- Hyperactivity Disorder; Hyperactivity |
Clinical Trial: Safety and Efficacy Study of Dexmethylphenidate in Children with ADHD
This study is no longer recruiting patients.
|
Purpose
The purpose of this study is to compare the safety and efficacy of two doses of dexmethylphenidate to two doses of an approved, long-acting, marketed medication for ADHD (MPH) and placebo in children ages 6-12 diagnosed with ADHD.
| Condition | Intervention | Phase |
|---|---|---|
| ADHD | Drug: Focalin XR | Phase III |
MedlinePlus related topics: Attention Deficit Disorder with Hyperactivity
Study Type: Interventional
Study Design: Prevention, Randomized, Double-Blind, Placebo Control, Crossover Assignment, Safety/Efficacy Study
Further Study Details:
Primary Outcomes: Reduction of symptoms in attention and deportment
Study start: May 2005
Eligibility
Ages Eligible for Study: 6 Years - 12 Years, Genders Eligible for Study: Both
Criteria
Inclusion Criteria:
- DSM-IV diagnosis of ADHD
- Males and females aged 6-12
Exclusion Criteria:
- Inability to understand or follow instructions
- Is pregnant
- Diagnosis of tic disorder
- History of seizure disorder
Location Information
Texas
Bayou City Research, Houston, Texas, 77007, United States
Study chairs or principal investigators
Matthew Brams, MD, Principal Investigator, Bayou City Research
More Information
Study ID Numbers: CRIT124EUS12
Last Updated: August 31, 2005
Record first received: August 30, 2005
ClinicalTrials.gov Identifier: NCT00141050
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-09-13
Last Updated: August 31, 2005
Record first received: August 30, 2005
ClinicalTrials.gov Identifier: NCT00141050
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-09-13
email this page
print this page
bookmark this page
feedback on this page
